Facts of ADCETRIS Brentuximab Vedotin ?
- Medicine Name: Adcetris
- Date of Approval:19.08.2011
- Company Name: Seattle Genetics, Inc.
- Treatment of: Hodgkin Lymphoma; Systemic Anaplastic Large Cell Lymphoma.
Adcetris contains the active substance brentuximab vedotin, an anti-cancer agent, which is made up of a monoclonal antibody linked to a substance intended to kill cancer cells. This substance is delivered to cancer cells by the monoclonal antibody. A monoclonal antibody is a protein which recognises certain cancer cells.
Adcetris is used to treat classical Hodgkin lymphoma that has:
Classical Hodgkin lymphoma expresses specific proteins on the cell surface that are different from non-classical Hodgkin lymphoma.
Adcetris is used to treat systemic anaplastic large cell lymphoma which is found in your lymph nodes and/or throughout other parts of your body that has:
Hodgkin lymphoma and systemic anaplastic large cell lymphoma are both types of cancer of the white blood cells.
Adcetris is a white to off-white cake or powder for concentrate for solution for infusion provided in a glass vial. Each pack of Adcetris consists of one vial.
Store in a refrigerator (2°C-8°C). Do not freeze. Keep the vial in the original carton in order to protect from light.For storage conditions after reconstitution and dilution of the medicinal product, see section 6.3.